Vireo Growth (VREOF) Share-based Compensation Growth (3y) (2023 - 2026)
Vireo Growth (VREOF) Share-based Compensation Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 10.35% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 40.57% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 67.91% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -28.57% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 12.76% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 20.51% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 17.07% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 37.54% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 18.39% |
| 10 | Vireo Growth | - | - | 59.30 Mn | 61.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.06% |
| Dec 31, 2025 | 141.11% |
| Sep 30, 2025 | 135.91% |
| Mar 31, 2025 | 26.48% |
| Dec 31, 2024 | 36.00% |
| Mar 31, 2024 | -50.03% |
| Dec 31, 2023 | -34.70% |
| Sep 30, 2023 | -26.15% |
| Jun 30, 2023 | -12.10% |
| Mar 31, 2023 | -15.08% |